Veterinary Clinical Trials Market To Reach $8.99 Billion By 2030

Veterinary Clinical Trials Market Growth & Trends

The global veterinary clinical trials market size is expected to reach USD 8.99 billion by 2030, exhibiting a CAGR of 9.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. The key factors driving industry growth include increased R&D expenditure by key players, rising prevalence of chronic diseases in animals, advancements in veterinary medicines, and rise in strategic alliances. For instance, in April 2024, Boehringer Ingelheim, a biopharmaceutical company focused on both human and animal health invested USD 593.5 Mn in animal health R&D to accelerate veterinary clinical trials as well as to develop innovative veterinary medicine.

Additionally, an increasing number of clinical trials for rare diseases in pets is expected to drive veterinary clinical trial market. Veterinary clinics and research institutions are undertaking specialized clinical trial initiatives focused specifically on rare canine cancers. These trials aim to investigate novel treatment approaches, including targeted therapies, immunotherapies, and precision medicine techniques designed for individual dogs' genetic profiles. For instance, in March 2024, Vivesto AB initiated its Paccal Vet clinical trial for dogs with splenic hemangiosarcoma, marking a significant step toward addressing this challenging cancer type in canines. The trial aims to assess the safety and efficacy of Paccal Vet, formulated with XR-17 technology, with promising results potentially leading to further pivotal studies.

There is a growing focus on preventive care in veterinary medicine. Clinical trials aimed at developing preventive treatments, such as vaccines and early diagnostic tools, are becoming more common. Furthermore, veterinary clinics and research institutions are launching specialized clinical trial initiatives focused specifically on rare canine cancers. These trials aim to investigate novel treatment approaches, including targeted therapies, immunotherapies, and precision medicine techniques tailored to individual dogs' genetic profiles.

 Request a free sample copy or view report summary: Veterinary Clinical Trials Market Report

Veterinary Clinical Trials Market Report Highlights

• Ongoing advancements in veterinary medicine drive the demand for veterinary clinical trials to improve animal health and welfare. Additionally, growing R&D investments by key players to innovate veterinary medicine are expected to boost market demand.

• By animal type,companion animal segment dominated the market in 2023 and is projected to witness the fastest growth rate of 9.5% in the coming years. Furthermore, among companion animals, canines segment is holding highest market share in 2023.

• In terms of indication, oncology segment dominated the market with a share of 27.51% in 2023, owing to the rising prevalence of cancers in animals and growing R&D investment for veterinary oncology. Whereas internal medicine segment is expected to grow at the fastest rate of over 10.2% in the coming years.

• Based on the sponsor, pharmaceutical and biopharmaceutical companies segment dominated the market in 2023, and the academics and research centers segment is expected to grow at the fastest rate of over 9.8% in the coming years.

• Medicines accounted for the largest market share by intervention type in 2023. However, medical device segment is estimated to witness the highest growth rate of around 10.0% in the near future.

• In 2023, North America held the highest share of 33.70% of the market by region.The Asia Pacific region is expected to grow at the fastest rate of over 10.1% in the coming years.

Veterinary Clinical Trials Market Segmentation

Grand View Research has segmented the global veterinary clinical trials market based on animal, indication, intervention, sponsor, and region:

Veterinary Clinical Trials Animal Outlook (Revenue, USD Million; 2018 - 2030)

• Companion Animal

  • Canine

  • Feline

  • Equine

• Livestock Animal

• Other Animals

Veterinary Clinical Trials Indication Outlook (Revenue, USD Million; 2018 - 2030)

• Oncology

• Internal Medicine

• Orthopedics

• Cardiology

• Neurology

• Ophthalmology

• Dermatology

• Other Indication

Veterinary Clinical Trials Intervention Outlook (Revenue, USD Million; 2018 - 2030)

• Medicines

• Medical Device

• Others

Veterinary Clinical Trials Sponsor Outlook (Revenue, USD Million; 2018 - 2030)

• Pharmaceutical And Biopharmaceutical Companies

• Academics And Research Centers

• Others

Veterinary Clinical Trials Regional Outlook (Revenue, USD Million; 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Sweden

  • Denmark

  • Norway

  • Rest of Europe

• Asia Pacific

  • Japan

  • China

  • India

  • South Korea

  • Australia

  • Thailand

  • Rest of Asia Pacific

• Latin America

  • Brazil

  • Argentina

  • Rest of Latin America

• Middle East & Africa    

  • Africa

  • Saudi Arabia

  • UAE

  • Kuwait

  • Rest of Middle East & Africa

List of Key Players in the Veterinary Clinical Trials Market

• Charles River Laboratory

• IDEXX Laboratories, Inc.

• Boehringer Ingelheim International GmbH.

• Argenta

• Bioagile Therapeutics Pvt. Ltd.

• Veterinary Research Management

• Merck & Co., Inc.

• Labcorp Drug Development

• OCR - Oncovet Clinical Research

• Vivesto AB

• Vetbiolix